ArticleInternational urology and nephrology2026

Assessing the real-world safety of sparsentan for immunoglobulin A nephropathy: insights from a comprehensive analysis of FAERS database.

Tailong Lv et al.PubMed ↗Publisher ↗

No numbers read from the abstract.